There is strong emerging evidence that Rac1 also contributes to the tumor stem cell phenotype, epithelial to mesenchymal transition (EMT), angiogenesis, and chemoresistance [33,34,35,36,37,38]. The gene discussed is RAC1; the disease is neoplasm.